一种简单高效扩增人ILC2s以预防急性GVHD的方法
本研究描述了一种快速扩增均一人ILC2s群的方法,扩增的ILC2s可在NOD scid gamma小鼠中减轻GVHD,培养中添加白介素4对防止促炎性ILC1样细胞扩增至关重要,该方法应允许评估人ILC2细胞治疗难治性胃肠道aGVHD。
要点
- 建立了一种快速扩增均一人ILC2s群的方法,扩增的ILC2s可在NOD scid gamma小鼠中减轻GVHD。
- 培养中添加白介素4对防止促炎性ILC1样细胞扩增至关重要。
- 该方法应允许评估人ILC2细胞治疗难治性胃肠道aGVHD。
核心结论
- 建立了一种快速扩增均一人ILC2s群的方法,扩增的ILC2s可在NOD scid gamma小鼠中减轻GVHD。
- 培养中添加白介素4对防止促炎性ILC1样细胞扩增至关重要。
- 该方法应允许评估人ILC2细胞治疗难治性胃肠道aGVHD。
研究设计与样本
- 本研究描述了一种快速扩增均一人ILC2s群的方法,并在NOD scid gamma小鼠中评估扩增的ILC2s对GVHD的作用。
主要发现
- 扩增的均一人ILC2s群可在NOD scid gamma小鼠中减轻GVHD。
- 培养中添加白介素4对防止促炎性ILC1样细胞扩增至关重要。
临床怎么用
- 作者认为,该方法应允许评估人ILC2细胞治疗难治性胃肠道aGVHD。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reconstitution of stem cells and enhancement of the barrier function of the gastrointestinal (GI) tract is critical to the resolution of intestinal acute graft-versus-host disease (aGVHD). Previously, our group has shown in murine models that type 2 innate lymphoid cells (ILC2s) generate proteins in the GI tract that enhanced GI tract barrier function, and diminished the expansion and function of proinflammatory donor cells when given to recipients of allogeneic stem cell transplant. Therefore, the infusion of donor ILC2s could treat or prevent GI tract aGVHD but, for this approach to be clinically applicable, robust expansion of a homogeneous population of human ILC2s is needed. Here, we describe a method for the rapid expansion of a uniform population of human ILC2s that decrease GVHD in NOD scid gamma mice. The addition of interleukin 4 to the culture was critical to prevent the expansion of proinflammatory ILC1-like cells. Our approach should allow for the evaluation of human ILC2 cells to treat therapy-resistant GI tract aGVHD.
引用
- Bruce DW, Laurie SJ, Xing Y, et al. A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD. Blood Adv. 2025. PMID: 40690747. doi:10.1182/bloodadvances.2024013609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。